Scientists designed and tested fluorescent molecules called “FibrilPaint” that bind exclusively to the long, thread-like ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Richard Oakley of the Alzheimer's Society spoke to Newsweek about why now is an "exciting time" in the battle against the ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

Village Caregiving reports that frontotemporal dementia is a progressive brain disease affecting behavior, speech, and memory ...

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

Early detection of Alzheimer's disease has come a step closer thanks to a new measurement method developed by chemists at ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Scientists on cusp of ‘very early’ dementia diagnosis after breakthrough - Science minister Patrick Vallance says he’s ‘super ...

Mixing up your children’s names, forgetting a neighbor’s name or not remembering the title of a movie can be unsettling and ...

The Justice Department unexpectedly dropped charges against a neuroscientist indicted for defrauding the NIH of approximately ...